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Abstract
Introduction. The impact of tumor cells on tumor-infiltrating lymphocytes (TILs) in cancer development is not 
yet clarified. Our study analyzed the distribution and prognostic value of CD4+ and CD8+ T lymphocytes in 
hepatocellular carcinoma (HCC) and liver metastases (LM). 
Material and methods. Archival tissue specimens of 35 HCC and 39 LM patients were immunohistochemically 
processed. The number of intratumoral (IT) and peritumoral (PT) CD4+ and CD8+ T cells was quantitatively 
analyzed. 
Results. We noted large variances of T lymphocyte subpopulations. Similar number of CD4+ and CD8+ lym-
phocytes was present in HCC, whereas in LM the number of CD8+ cells was approximately two times higher 
than CD4+ lymphocytes. A significant prevalence of T cells in PT over IT areas was observed. The prognostic 
value was demonstrated only for PT CD8+ lymphocytes in LM, their reduced number being associated with 
shorter survival.
Conclusions. The differences between proportions of T lymphocytes within tumor and its environment might 
be explained by proapoptotic effect of cancer cells on TILs. (Folia Histochemica et Cytobiologica 2015, Vol. 53, 
No. 3, 272–281)
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Introduction
Characterization of tumor microenvironment holds 
a key role in the attempt to understand the mechanism 
of primary and secondary liver carcinogenesis, its 
immune component, responsible for the development 
of an immune response of the host against the tumor, 
being the main point of interest [1–4]. The largely 
inconsistent biological behavior of primary and se-
condary liver tumors could be also explained by the 
settled relationship between the tumoral component 
and microenvironment [1, 5, 6]. 
Although the role of lymphocytes in immunity was 
stated for the first time over one hundred years ago, 
the first report which proved the correlation between 
the increased number of cytotoxic CD8+ T lympho-
cytes and the favorable prognosis in melanoma tumor 
pathology had been published in 1989 [7]. The study 
on colorectal cancer showed the involvement of T lym-
phocytes in destruction of cancer cells within tumor and 
called them tumor-infiltrating lymphocytes (TILs) [8].
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The ratios between CD4+ and CD8+ T lym-
phocytes within TILs are variable, depending not 
only on the investigated tumor type, but also on the 
quantification method. However, numerous studies 
on colorectal [9], ovarian [10], breast [11, 12], and 
esophageal cancer [13], leukemia [14], and other ma-
lignancies confirmed the protective prognosis value 
of the immune infiltrate with CD8+ T lymphocytes 
[15]. Nevertheless, there are conflicting results, such 
as in melanoma, where TILs influence survival either 
positively [16, 17] or negatively [18, 19].
All these data support the fact that despite con-
certed efforts towards the decoding of a stable pattern 
in the relationship between the presence of TILs and 
tumor behavior, the dilemma regarding the position of 
TILs as friend or foes [20] is still present. The review 
of the literature reveals attentiveness to the inves-
tigation of TILs in hepatic parenchyma, in primary 
tumor context — namely hepatocellular carcinoma 
(HCC) [3, 21–32] or in liver metastases (LM) [33–35]. 
Nevertheless, we have to highlight the fact that none 
of the published studies presented comparative data 
of CD4+ and CD8+ T lymphocytes in primary versus 
secondary liver tumors. 
Within this framework, our study focused on the 
investigation of the immune infiltrates in HCC and 
LM, using a comparative evaluation of intratumoral 
and peritumoral CD4+ and CD8+ T lymphocytes, 
respectively, with the aim to ascertain the value of 
their ratio as a prognostic factor. 
Material and methods
Patients. The studied material consisted of paraffin-embed-
ded tissue specimens corresponding to 35 patients with HCC 
(Group 1) and 39 patients with LM (Group 2) diagnosed 
and surgically treated between January 2009 and December 
2011 at “Sf. Spiridon” University Hospital, Iaşi. 
The study was approved by the Ethics Committee of the 
University of Medicine and Pharmacy “Grigore T. Popa”, 
Iaşi, Romania.
The clinicopathological features are presented in Table 1; 
the tumor stage and histological grade both for HCC and 
LM were established according to the criteria of pTNM 
classification [36]. The patients did not receive preoperative 
chemotherapy or radiotherapy. 
All documented patients’ deaths were related to previ-
ously diagnosed cancer disease. The median survival rates 
were 5 months for HCC and 17 months for LM cases. Ac-
cording to follow-up records, 36.12% of HCC patients and 
27.78% of LM patients were alive at the 31st of January 2013. 
Immunohistochemistry. For each case, a single paraffin-em-
bedded block, considered as representative for the tumoral 
features and inflammatory infiltrate was chosen. Immuno-
histochemical (IHC) staining was performed on 4-µm-thick 
paraffin sections placed on coated microscopic slides, spe-
cially treated for immunohistochemistry (Thermo Fischer 
Scientific, Fitchburg, WI, USA). The slides were then dried 
at room temperature (RT) and heated in an oven at (58°C 
for 60 min, for a greater adherence of the tissue. Standard 
protocol for IHC technique was used. First, the slides were 
dewaxed in two baths of xylene and hydrated in four baths of 
graded alcohol (100%, 90%, 80%, 70%), 10 min each, than 
rinsed in distilled water. To unmask the antigenic site, slides 
were placed in antigen retrieval solution pH 6.0 (citrate-based 
buffer — Novocastra Epitope Retrieval Solutions Leica Bio-
system, Newcastle Ltd, United Kingdom) and heated at 98°C 
for 30 min (HIER technique). After blocking the endogenous 
peroxidases in 3% hydrogen peroxide solution, for 10 min, 
slides were incubated with the primary antibodies, overnight 
at 4°C, in a humidified chamber. We used anti-CD4 (Clone 
4B12, code NCL-L-CD4-368, Novocastra; dilution 1:40) and 
anti-CD8 (Clone 1A5, code NCL-L-CD8-295, Novocastra; 
dilution 1:80). For the horseradish peroxidase (HRP) enzy-
matic detection of reaction the slides were incubated with the 
secondary antibody and the polymer for 30 min each, at RT 
(Novolink polymer kit, Novocastra). Reaction was developed 
with DAB (3.3’-diaminobenzidine dihydrochloride) chromo-
gen, for 5 min at RT, till a brown stain appeared. Slides were 
then rinse in running tap water for 5 min and counterstained 
with hematoxylin. Negative (omitting the incubation with the 
primary antibody) and positive (tonsil) controls were run in 
the same staining session.
Quantitative analysis. TILs were assessed by using an adap-
ted methodology [37]. The number of CD4+ and CD8+ 
T lymphocytes, respectively, was counted in 10 microscopic 
fields per each section (slide) corresponding to each case 
at total magnification of × 200, independently by two histo-
pathologists (S.E.G. and E.R.A.) for intratumoral (IT) and 
peritumoral (PT) areas. The peritumoral areas were defined 
outside the proper tumor field areas, at the border between 
the tumoral cells and hepatocytes’ layers belonging to the 
normal liver parenchyma. A mean value/case was calculated 
for each lymphocytes subtype and territory. Subsequently, by 
using the mean values/case, we computed the mean value for 
Group 1 and Group 2, for CD4+ and CD8+ T lymphocytes, 
and IT and PT territory, respectively.
Statistical analysis. Mean values of either CD4+ or CD8+ 
cells in respective territories were used as threshold in order 
to obtain subgroups including cases with lower and, respec-
tively, higher CD4+/CD8+ lymphocytes mean value/case 
than the threshold. Statistical analysis has been performed 
using MedCalc software (MedCalc Software, Ostend, Bel-
gium) and GraphPad Prism — ver. 6.05 (GraphPad Software 
Inc., La Jolla, CA, USA). Patients’ characteristics were 
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given in absolute and relative numbers or as mean values 
with standard error of the mean (SEM). Mean lymphocytes 
values were further checked with the use of D’Agostino 
normality test, and the Fisher 2 × 2 exact test was used to 
analyze relationships between the subgroups. Mann-Whit-
ney U test was applied to check the statistical differences 
between two groups. Spearman’s correlation was utilized for 
testing the associations between variables. The Cox-Mantel 
proportional hazard regression model was used to evaluate 
the effect of explorative variables on survival of HCC and 
LM patients. Firstly, univariate Cox regression analysis for 
every single variable was performed. Secondly, variables 
with a p value < 0.05 were included into multivariate Cox 
regression analysis with a variable selection via backward 
Table 1. Clinicopathological characteristics of patients with hepatocellular carcinoma and liver metastases
Clinicopathological
characteristics
Variable description Patients’ number %
Hepatocellular carcinoma
Age (years) 62.9 ± 10.7; 64; 23–83*
£ 63
> 63
17
18
48.57
51.43
Gender
Female
Male
12
23
34.29
65.71
Tumor stage**
Stage I
Stage II
Stage IIIa
Stage IV
T1N0M0
T2N0M0
T3N0M0
TxNxM1
5
13
16
1
14.29
37.14
45.71
2.86
Histological grade**
G1
G2
G3
Well differentiated
Moderately differentiated
Poorly differentiated
13
15
7
37.14
42.86
20.00
Liver metastases
Age (years) 67.6 ± 11.9; 70; 35–86*
£ 68
> 68
17
22
43.59
56.41
Gender
Female
Male
18
21
46.15
53.85
Tumor stage
Stage IV TxNxM1 39 100
Histological grade
G1
G2
G3
G4
Well differentiated
Moderately differentiated
Poorly differentiated
Undifferentiated
3
20
14
2
7.69
51.28
35.90
5.13
Tumoral extension
One lobe
Many lobes
26
13
66.67
33.33
Origin
Colon
Rectum
Duodenum
Stomach
Pancreas
Gallbladder
Adrenal gland
Breast
Ovary
18
6
1
8
2
1
1
1
1
46.15
15.39
2.56
20.53
5.13
2.56
2.56
2.56
2.56
*Mean ± SD; median; range; **pTNM stages (IIIb, IIIc) and G4 were not diagnosed, and, therefore, not shown
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elimination. All associations were presented as hazard ratios 
(HR) with their 95% confidence interval (CI) and p values. 
Variables for overall survival (OS) and progression-free sur-
vival (PFS) rates were calculated separately. Kaplan-Meier 
estimations were performed to describe survival rates.
Results
Qualitative analysis of T cells populations  
in HCC and LM
The microscopic examination revealed both in HCC 
(Group 1) and LM (Group 2) a similar distribution 
pattern for CD4+ and CD8+ T lymphocytes, with 
an obvious cellular predominance in the PT area, 
especially at the border with normal liver paren-
chyma (tumor’s invasion front), compared with IT 
localization (Figure 1A–D). We noted a specific PT 
arrangement of CD4+ and CD8+ T lymphocytes, 
around the tumoral islands, as condensed layers or 
mantle zones, or as compact structures resembling 
lymphoid nodules, whereas they were isolated or 
dispersed within the tumoral mass.
Quantitative analysis of T cell populations  
in HCC and LM
We found similar number of CD4+ and CD8+ cells 
in HCC (CD8+ mean value 148.5 ± 114.03 vs. CD4+ 
mean value 140.01 ± 84.16), whereas in LM the 
number of CD8+ cells was increased in comparison 
with CD4+ cells (approximately × 1.8 higher, CD8+ 
mean value 108.7 ± 12.8 vs. CD4+ mean value 
60.49 ± 10.88, p < 0.0001). 
When the T lymphocytes’ populations were di-
vided according to intra- or peritumoral location, 
we observed a significant prevalence of T cells in 
peritumoral over intratumoral tissue. In HCC the 
PT/IT ratio was 3.5 for CD8+ (PT mean value 
231.70 ± 162.66 vs. IT mean value 65.3 ± 65.4) and 
5.5 for CD4+ cells (PT mean value 237.05 ± 149.77 
vs. IT mean value 43.10 ± 52.39); statistical analysis 
revealed significant differences for both CD4+ and 
CD8+ lymphocytes, intratumoral vs. peritumoral 
(p < 0.0001); no significant differences were found 
between CD4+ and CD8+ cells, when we com-
pared their number in IT and PT areas, respectively 
(Figure 2A). In LM the ratios were 4.3 for CD8+ 
(PT mean value 176.00 ± 120.13 vs. IT mean value 
41.10 ± 0.47) and 10.0 for CD4+ cells (PT mean 
value 109.9 ± 160.93 vs. IT mean value 11.00 ± 
1.55); statistical analysis revealed significant differ-
ences between IT and PT area for both CD4+ and 
CD8+ cells (p < 0.0001), and also between CD4+ 
and CD8+ cells, in IT (p < 0.0001) and PT areas 
(p < 0.005) (Figure 2B).
Figure 1. The distribution of T lymphocytes in hepatic tumors’ environment shows similar pattern in hepatocellular carci-
noma (A: CD4+ cells, B: CD8+ cells) and liver metastases (C: CD4+ cells, D: CD8+ cells). Total magnification × 200
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The correlation analysis between the number of 
lymphocytes in IT and PT areas revealed a medium 
positive association between either CD4+ or CD8+ 
cells in correspondence to HCC, whereas in LM the 
results indicated a weak relationship for both subtypes 
of T lymphocytes (Figure 3). 
Figure 2. Comparison between number of intratumoral (IT) and peritumoral (PT) CD4+ and CD8+ lymphocytes in 
hepatocellular carcinoma (HCC, A) and liver metastases (LM, B). Bars and whiskers represent mean values ± SEM.  
**p < 0.005, ****p < 0.0001; Mann-Whitney U test
Figure 3. Correlation plots of peritumoral (PT) and intratumoral (IT) CD4+ and CD8+ lymphocytes’ number in hepato-
cellular carcinoma (HCC) and liver metastases (LM). Spearman’s correlation test
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When the threshold values were applied for 
T cells’ populations according to mean values (bars in 
Figures 2A, B), the association between the defined 
subgroups and clinical variables (Table 2) was tested; 
age > 63 was partially connected with decreased num-
ber of both populations of T lymphocytes. Moreover, 
we observed that decreased number of CD4+ cells 
within metastasized cancer islets was associated with 
increased number of lobes in LM. 
Survival analysis
Based on Cox survival test and Kaplan-Meier plot 
we observed that the advanced stages (III and IV) 
in HCC and loss of histological differentiation (poor 
and undifferentiated grade) in LM are connected 
with shorter median OS rate (Figure 4). When 
we focused on T cells populations, the decreased 
number of CD8+ cells in area surrounding tumor 
in LM was associated with shorter OS (Figure 4). 
We also checked the PFS rates and no associations 
were found, neither based on clinical or morpho-
logical data.
Cox hazard test analysis revealed no significant 
relationship between variables and OS with the ex-
ception of HCC TNM staging. On the contrary, for 
LM we found that decreased number of peritumoral 
CD8+ lymphocytes may have independent prognostic 
value in LM cases with poorly or undifferentiated 
grade (Table 3). Again, for PFS data we found no 
connections with clinical and morphological findings.
Discussion
Despite the current knowledge on the complex be-
havior of TILs in the hepatic microenvironment [20, 
38, 39], several issues are still in debate. It is unani-
mously accepted that the immune cells may inhibit 
the tumor growth and progression by malignant cells 
recognition and elimination, processes defined as 
immunesurveillance [40, 41]. If immunesurveillance 
Table 2. Clinical data of patients with hepatocellular carcinoma or liver metastases in relation to the threshold number of 
CD4+ and CD8+ lymphocytes in intratumoral and peritumoral territories
CD4+ lymphocytes CD8+ lymphocytes
Clinicopathological  
characteristics
Intratumoral territory Peritumoral territory Intratumoral territory Peritumoral territory
T
ò vs. ñ
T
ò vs. ñ
T
ò vs. ñ
T
ò vs. ñ
Hepatocellular carcinoma
Age (years)
< 63
≥ 63
Tumor stage
I–II
III–IV
Histological grade
G1–G2
G3
13 vs. 3
p = 0.07
9 vs. 10
13 vs. 6
p = 0.50
9 vs. 7
16 vs. 12
p = 0.21
6 vs. 1
6 vs. 10
p = 0.5
10 vs. 9
8 vs. 11
p = 0.73
8 vs. 8
15 vs. 13
p = 0.09
1 vs. 6
14 vs. 2
p = 0.03
10 vs. 9
13 vs. 6
p = 1
11 vs. 5
19 vs. 9
p = 1
5 vs. 2
10 vs. 6
p = 0.31
8 vs. 11
8 vs. 11
p = 0.31
10 vs. 6
15 vs. 13
p = 0.69
3 vs. 4
Liver metastases
Age (years)
≤ 68
> 68
Histological grade
G1–G2
G3–G4
Tumor extension
One lobe
Many lobes
12 vs. 6
p = 1
15 vs. 6
15 vs. 8
p = 0.72
12 vs. 4
17 vs. 9
p = 0.71
10 vs. 3
8 vs. 10
p = 0.02
17 vs. 4
15 vs. 8
p = 1
10 vs. 6
14 vs. 12
p = 0.02
12 vs. 1
11 vs. 7
p = 1
13 vs. 8
14 vs. 9
p = 1
10 vs. 6
16 vs. 10
p = 1
8 vs. 5
12 vs. 6
p = 0.51
11 vs. 10
14 vs. 9
p = 1
9 vs. 7
15 vs. 11
p = 1
8 vs. 5
T — threshold (mean value/group), ò — number of cases with CD4+/CD8+ lymphocytes mean value/case lower than threshold, ñ — number of cases 
with CD4+/CD8+ lymphocytes mean value/case higher than threshold; (Fisher’s 2 × 2 test)
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fails, the tumor cells could be either chronically pre-
served or modified by the interactions with immune 
cells, generating new tumor variants able to escape 
the immune system by several mechanisms [40, 41]. 
Therefore, the immunodeficient status may facilitate 
the risk of tumor development — an event amplified 
Figure 4. Kaplan-Meier curves show the prognostic value of tumor stage in hepatocellular carcinoma (HCC), and of 
peritumoral CD8+ lymphocytes and histological grade in liver metastases (LM)
Table 3. Selection of univariate and multivariate Cox regression analyses of overall survival rates in hepatocellular carci-
noma and liver metastases
Parameters Univariable analysis Multivariable analysis
p value Hazard ratio  
(95% CI)
p value Hazard ratio  
(95% CI)
Hepatocellular carcinoma
Tumor stage  
≥ III vs. ≤ II 0.033 2.51 (1.07–5.86)
Liver metastases
Histological grade
G3–4 vs. G1–2 0.009 2.82 (1.28–6.20) 0.006 2.98 (1.35–6.55)
Peritumoral CD8+
ò vs. ñ 0.049 0.45 (0.19–1.06) 0.047 0.42 (0.18–0.99)
Cox analysis of ñ vs. ò means that the hazard ratio (HR) and p values are related to the occurrence of decreased number of T cells; only results 
with p < 0.05 were shown
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also by the tumor potential to generate an immuno-
suppressive microenvironment which prevents the 
antitumor immunity. The variability of the cellular 
and molecular cross-talk in tumor microenvironment 
(yet impossible to quantify) directly induces the varia-
bility of the antitumoral or/and protumoral capacity 
expression. As a consequence, the mechanisms which 
regulate TILs pro- or antitumoral activity have not 
been satisfactorily understood.
Within this context, we focused on the study of 
CD4+ and CD8+ T lymphocytes present in the he-
patic microenvironment in two different conditions, 
namely HCC — as a primary tumor — and liver meta-
stases. Our comparative analysis aimed to identify the 
similarities and differences between the lymphocytes’ 
numbers in intra- and peritumoral tissues (including 
the relationship with survival) in the progression of 
primary and secondary tumor, respectively.
Despite the differences in the pathomechanisms 
of the primary or secondary neoplastic process, we 
noted a similar pattern of T lymphocytes’ distribution 
in HCC and LM, characterized by a higher number of 
both major types of T cells in PT area, at the invasive 
front, and their lower number inside the tumor tissue. 
Such observation has been refined by the separate 
quantitative assessment of CD4+ and CD8+ lym-
phocytes and statistical analysis that outlined two 
important differences between HCC and LM. 
Firstly, HCC presented a quite similar number of 
CD4+ and CD8+ lymphocytes, whereas in LM the 
number of CD8+ cells was approximately twice than 
CD4+ lymphocytes. These data obviously indicates 
a different behavior of CD4+ and CD8+ lymphocyte 
subpopulations in primary versus secondary liver 
tumors. Quantitative arguments which attest CD8+ 
prevalence in LM suggest a stronger antitumor de-
fense reaction in comparison to HCC. A possible 
explanation of enhanced CD8+ cells number in 
LM than in HCC may be related to the increased 
tumor angiogenesis in metastases [42–44] and to the 
intrinsic relationship between proangiogenic factors 
and TILs [45, 46]. 
Secondly, we noted the significant decrease of 
both CD4+ and CD8+ cells within liver tumor as 
compared to its margin. Such observation supports 
the cross-talk between cancer and liver microenvi-
ronment [47] and the indirect tumor-T cell “fatal” 
relationship may develop at least in two ways. 
Fas-dependent induced apoptosis of activated 
T cells may be induced by tumoral cells expressing 
FasL. Such FasL-counterattack was found in non- 
-small cell lung [48] and kidney cancer [49], but it is 
also characteristic for metastatic colorectal cancer 
(CRC) [50]. Since CRC was primary tumor site in 
most patients with liver metastases we suppose that 
this tumor-lymphocyte relation may have strong 
connections with decreased number of intratumoral 
T lymphocytes in LM in comparison to HCC. 
Another possible mechanism related to the low 
number of CD8+ cells may be associated with the 
presence of B7-H1 signaling molecule on tumor-in-
filtrating macrophages (TAMs) [51]. It was noted 
that TAMs play important role in tumor development 
and progression in liver [47]. TAMs are lured and 
activated by cancer cells, which secrete either M-CSF 
(macrophage colony stimulating factor) [47] or/and 
CEA (carcinoembryonic antigen) [52]. Our previous 
report showed that number of TAMs in LM was as-
sociated with overall survival (OS) [53]. TAMs were 
found as a main source of B7-H1 signaling molecule, 
which connects to PD-1 death receptor on activated 
CD8+ cells and therefore induces their apoptosis 
[51]. Since the number of T cells is much higher in the 
peritumoral tissue, we suppose that the T-cell specific 
pro-apoptotic signals triggered by cancer cells play 
a main role in the decrease of number of T cells in 
liver tumors, regardless of cancer origin. 
Furthermore, the important role of CD8+ cells in 
inhibition of tumor progression was proven by survival 
analysis, since decreased number of CD8+ lympho-
cytes was associated with shorter OS in patients with 
liver metastases. Our results supplement the reports 
by other authors that support the positive prognosis 
value of CD8+ T lymphocytes in LM [33–35]. 
Concerning the relationship between the lympho-
cytes and clinicopathological parameters, our data 
showed lack of correlations, except for the reduced 
number of CD8+/CD4+ lymphocytes and age over 
63 or 68 years for HCC and LM respectively, and 
for the decreased number of intratumoral CD4+ 
lymphocytes and the increase of lobular extension 
in LM. These results reflect the difficulty to confirm 
the direct connection of lymphocytes to the clinical 
behavior of the tumors, either primary or secondary.
Finally, the main question that rises is related to 
the mechanisms that govern different antitumoral 
responses in primary and secondary tumors, respec-
tively. Based on the above mentioned results, we can 
reiterate the intervention of the tumor FasL-counter-
attack or B7-H1 secretion. 
Moreover, the absence of the correlation be-
tween TILs and survival in HCC can be interpreted 
as a consequence of an intense loss of lymphocytes 
through the proapoptotic processes that develop in 
the microenvironment of liver parenchyma. It is pos-
sible that in HCC these processes act on CD4+ and 
CD8+ T cells both in intra- and peritumoral tissue 
(and not only on IT lymphocytes as in LM). Such 
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possibility offers new alternative for understanding 
lymphocytes’ role in primary and secondary tumor 
progression than the widely-held paradigm based 
on the intratumoral balance between regulatory and 
cytotoxic T lymphocytes [20, 38, 39] and the obligatory 
role of CD4+ T cells recruitment for the induction of 
an efficient antitumoral action of CD8+ T cells [35].
A special remark is compulsory to justify the metho- 
 dology of our study that uses only the immunohisto-
chemical assessment of the lymphocytic populations. 
At a glance, the absence of the advanced molecular 
biology techniques (e.g. cytometric analysis of tissue 
homogenates that can offer by ex vivo manipulation 
a better understanding of the in vivo cellular expression 
[54] could be considered as a major limitation for the 
obtained results. However, the morphological ap-
proach is much better suited for the identification and 
counting of CD4+ and CD8+ lymphocytes in their 
proper location in liver parenchyma, as shown by us 
for intra- and peritumoral territories. This approach 
made it possible to perform analysis of the correlation 
between the T lymphocytes’ number and survival due 
to the use of the archived tumoral tissues.
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